Randhawa Simratinsider trades
In SEC Form 4 filings, Randhawa Simrat is listed as EVP, Head of R&D of Dianthus Therapeutics, Inc. /DE/ (DNTH). In the last 90 days, Randhawa Simrat sold $2.46M of Dianthus Therapeutics, Inc. /DE/ (DNTH) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| DNTHDianthus Therapeutics, Inc. /DE/ | EVP, Head of R&D | 9 | Sep 3 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 1 | Sep 3 | M | 7,500 | $17.88 | $134,100 | 11,500 | Yes | Form 4 |
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 1 | Sep 3 | M | 6,249 | $21.77 | $136,041 | 17,749 | Yes | Form 4 |
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 1 | Sep 3 | M | 9,375 | $22.07 | $206,906 | 27,124 | Yes | Form 4 |
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 1 | Sep 3 | S | 2,600 | $105.19 | Sale −$273,494 | 24,524 | Yes | Form 4 |
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 1 | Sep 3 | S | 7,215 | $106.25 | Sale −$766,594 | 17,309 | Yes | Form 4 |
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 1 | Sep 3 | S | 13,309 | $106.74 | Sale −$1,420,603 | 4,000 | Yes | Form 4 |
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 1 | Sep 3 | M · derivative | 7,500 | $17.88 | $134,100 | 56,776 | Yes | Form 4 |
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 1 | Sep 3 | M · derivative | 6,249 | $21.77 | $136,041 | 41,676 | Yes | Form 4 |
| DNTHDianthus Therapeutics, Inc. /DE/ | Sep 1 | Sep 3 | M · derivative | 9,375 | $22.07 | $206,906 | 87,500 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.